(E)-2-(3-(6-bromobenzo[d][1,3]dioxol-5-yl)acrylamido)cyclohex-1-enecarboxylic acid

ID: ALA3297799

Chembl Id: CHEMBL3297799

PubChem CID: 90682776

Max Phase: Preclinical

Molecular Formula: C17H16BrNO5

Molecular Weight: 394.22

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(/C=C/c1cc2c(cc1Br)OCO2)NC1=C(C(=O)O)CCCC1

Standard InChI:  InChI=1S/C17H16BrNO5/c18-12-8-15-14(23-9-24-15)7-10(12)5-6-16(20)19-13-4-2-1-3-11(13)17(21)22/h5-8H,1-4,9H2,(H,19,20)(H,21,22)/b6-5+

Standard InChI Key:  SUKSRMSXXNDRGA-AATRIKPKSA-N

Associated Targets(Human)

HCAR2 Tclin Hydroxycarboxylic acid receptor 2 (1903 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCAR3 Tchem HM74 nicotinic acid GPCR (353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCAR1 Tchem G-protein coupled receptor 81 (382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 394.22Molecular Weight (Monoisotopic): 393.0212AlogP: 3.22#Rotatable Bonds: 4
Polar Surface Area: 84.86Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 2.39CX Basic pKa: CX LogP: 2.85CX LogD: -0.67
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.77Np Likeness Score: -0.09

References

1. Bobileva O, Bokaldere R, Gailite V, Kaula I, Ikaunieks M, Duburs G, Petrovska R, Mandrika I, Klovins J, Loza E..  (2014)  Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists.,  22  (14): [PMID:24864041] [10.1016/j.bmc.2014.05.011]

Source